Topic: AS01-Diagnosis/AS01c-Molecular aberrations (cytogenetic, genetic, gene expression): ADVOCATING FOR NGS IN THE CLINICAL SETTING; VARIANTS IDENTIFIED THROUGH MOLECULAR PROFILING ARE CLINICALLY ACTIONABLE IN MANY PATIENTS WITH CCUS, MDS, AND OTHER MYELOID MALIGNANCIES. (September 2021)